हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
Indian pharmaceutical industries
Indian pharmaceutical industries News
Ranbaxy
03 Dec 2014
After US, Germany bans export of Ranbaxy's Dewas plant drugs
In fresh overseas troubles, drugmaker Ranbaxy has been barred from exporting certain antibiotics produced at its Dewas plant to Germany for non-compliance to 'good manufacturing practice' norms.
Sun Pharma
13 Nov 2014
Sun Pharma Q2 net profit up 15% at Rs 1,572 cr
Sun Pharma Thursday said its consolidated net profit rose by 15 percent to Rs 1,572 crore for the second quarter ended September 30.
Dr Reddy's
29 Oct 2014
Dr Reddy's Q2 net down 17% at Rs 574.1 cr
Net income during the period under review stood at Rs 3,587.81 crore as against Rs 3,357.45 crore in the year-ago period, Dr Reddy's Laboratories said in a filing to BSE.
Lupin
28 Oct 2014
Lupin Q2 net profit up 55% at Rs 630 crore
Drug major Lupin Tuesday posted 55.11 percent rise in its consolidated net profit at Rs 630.04 crore for the second quarter ended September 30, driven by robust sales in the US, Japan and domestic market.
Ranbaxy Laboratories
28 Oct 2014
Ranbaxy posts Q2 net profit of Rs 477.75 cr
Drug firm Ranbaxy Laboratories Tuesday reported a consolidated net profit of Rs 477.75 crore for the quarter ended September 30, 2014 on account of robust sales.
GVK Biosciences
01 Oct 2014
GVK Bio under scanner of European Drug Regulator
The European Medicines Agency (EMA) has started a review in connection with findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences, a city-based Contract Research Organisation.
738259
1
0
Loading...
Trending news
DNA Video
DNA: Is the Opposition to ‘Bantenge To Katenge’ Part of a Larger Plan?
DNA Video
DNA: RSS Master Plan: From Maharashtra to UP
DNA Video
DNA: Bengal’s Waqf Property Controversy
DNA Video
DNA: Is ‘Vote Jihad’ a Reality in Maharashtra?
DNA Video
DNA: Naresh Meena Slaps Officer, Sparks Uproar in Tonk
DNA Video
DNA: Maryam Nawaz vs. Bhagwant Mann: The Pollution Blame Game
DNA Video
DNA: Owaisi’s “15-Minute” Politics Heats Up Again
DNA Video
DNA: Sajjad Nomani’s Appeal for Muslim Votes Sparks Debate
DNA Video
DNA: Supreme Court Halts Bulldozer Justice, Warns Officials
DNA Video
DNA: RSS Mobilizes in Maharashtra’s Muslim Areas for BJP Support
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK